ロード中...
Tranilast enhances the effect of anticancer agents in osteosarcoma
Tranilast [N-(3′,4′-dimethoxycinnamoyl)-anthranilic acid], initially developed as an antiallergic drug, also exhibits a growth inhibitory effect on various types of cancer. Osteosarcoma is treated mainly with high-dose methotrexate, doxorubicin, cisplatin and ifosfamide; however, 20–30 % of patients...
保存先:
| 出版年: | Oncol Rep |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6549073/ https://ncbi.nlm.nih.gov/pubmed/31059083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7150 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|